| Product Name | CAS No. | Inquiry |
|---|
|
Guanidineacetic acid |
352-97-6 |
Inquire |
|
2-Fluoro-4-nitrobenzoic acid |
403-24-7 |
Inquire |
|
2-C-Methyl-D-ribono-1,4-lactone |
492-30-8 |
Inquire |
|
5-Methylnicotinic acid |
3222-49-9 |
Inquire |
|
Coptisine chloride |
6020-18-4 |
Inquire |
|
2,3,5-Tri-O-benzoyl-2-C-methyl-D-ribonic acid-1,4-lactone |
7392-74-7 |
Inquire |
|
Benzodioxole-4-carboxaldehyde |
7797-83-3 |
Inquire |
|
1,2,3,5-Tetra-O-benzoyl-2-C-methyl-beta-D-ribofuranose |
15397-15-6 |
Inquire |
|
4-Amino-3-chlorophenol |
17609-80-2 |
Inquire |
|
2,3-Dihydroxybenzaldehyde |
24677-78-9 |
Inquire |
|
Clindamycin hydrochloride monohydrate |
58207-19-5 |
Inquire |
|
Olopatadine |
113806-05-6 |
Inquire |
|
Olopatadine hydrochloride |
140462-76-6 |
Inquire |
|
4-Isothiocyanato-2-(trifluoromethyl)benzonitrile |
143782-23-4 |
Inquire |
|
4,6-Dichloro-5-(4-bromophenyl)pyrimidine |
146533-41-7 |
Inquire |
|
N-Propylsulfamide |
147962-41-2 |
Inquire |
|
Rupatadine fumarate |
182349-12-8 |
Inquire |
|
4-[(6,7-Dimethoxyquinolin-4-yl)oxy]aniline |
190728-25-7 |
Inquire |
|
1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid |
849217-48-7 |
Inquire |
|
N-Methyl-2-fluoro-4-nitrobenzamide |
915087-24-0 |
Inquire |
|
N-Methyl-2-fluoro-4-aminobenzamide |
915087-25-1 |
Inquire |
|
4-[(2-Cyanopropan-2-yl)amino]-2-fluoro-N-methylbenzamide |
915087-32-0 |
Inquire |
|
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone |
915095-86-2 |
Inquire |
|
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan |
915095-89-5 |
Inquire |
|
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan |
915095-94-2 |
Inquire |
|
1-Chloro-5-isopropoxy-2-methyl-4-nitrobenzene |
1032903-50-6 |
Inquire |
|
1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene |
1202858-68-1 |
Inquire |
|
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine ethyl ester |
1258638-92-4 |
Inquire |
|
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine |
1289942-66-0 |
Inquire |
|
N-Propyl-sulfamide potassium salt |
1393813-41-6 |
Inquire |
|
